MedTrace Logo

Bariatric Endoscopy and NAFLD

NCT04895943 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-01-18

No results posted yet for this study

Summary

Find out how bariatric endoscopy will influence the clinical course of non-alcoholic fatty liver disease.

Conditions

  • Obesity
  • NAFLD
  • Liver Steatosis
  • Liver Fibrosis

Interventions

PROCEDURE

bariatric endoscopy, mainly intragastric balloons, plication of the stomach too

bariatric endoscopy, mainly intragastric balloons, plication of the stomach too

PROCEDURE

bariatric endoscopy, mainly intragastric balloons, plication of the stomach too

bariatric endoscopy, mainly intragastric balloons, plication of the stomach too

Sponsors & Collaborators

  • University Hospital Ostrava

    lead OTHER

Principal Investigators

  • Adam Vašura, MD · University Hospital Ostrava

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-29
Primary Completion
2023-12-31
Completion
2024-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04895943 on ClinicalTrials.gov